Wells Fargo & Company THERIVA BIOLOGICS INC Transaction History

Wells Fargo & Company

  • $407 Billion
  • Q2 2024
Number of Shares
100
Previous 233 57.08%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
N/A
-133 Reduced 57.08%
100 $0
Q1 2024

May 10, 2024
BUY
N/A
2 Added 0.87%
233 $0
Q4 2023

Feb 09, 2024
BUY
N/A
107 Added 86.29%
231 $0
Q3 2023

Nov 13, 2023
BUY
N/A
15 Added 13.76%
124 $0
Q2 2023

Aug 15, 2023
SELL
N/A
-1 Reduced 0.91%
109 $0
Q1 2023

May 12, 2023
BUY
N/A
2 Added 1.85%
110 $0
Q4 2022

Feb 13, 2023
BUY
N/A
3 Added 2.86%
108 $0
Q3 2022

Nov 14, 2022
BUY
N/A
105 New
105 $0
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email